Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiro Takahashi

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Dermatology|October 19, 2017
Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosisMegumi Hirabayashi, Yoshihide Asano, Takashi Yamashita, et al.
Modern Rheumatology|March 6, 2014
Effect of ambrisentan on peripheral circulation in patients with systemic sclerosisHayakazu Sumida, Yoshihide Asano, Masaru Hatano, et al.
Plos One|March 3, 2012
A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosisShinji Noda, Yoshihide Asano, Kaname Akamata, et al.
The Journal of Dermatology|May 8, 2014
Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosusHayakazu Sumida, Yoshihide Asano, Zenshiro Tamaki, et al.
Journal of Dermatological Science|October 2, 2018
Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosisTakashi Yamashita, Yoshihide Asano, Ryosuke Saigusa, et al.
Journal of Dermatological Science|October 1, 2018
Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized sclerodermaTakuya Miyagawa, Yohei Ichimura, Kouki Nakamura, et al.
Modern Rheumatology|September 14, 2012
Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosisTakehiro Takahashi, Yoshihide Asano, Kaname Akamata, et al.
International Journal of Dermatology|September 1, 2018
Assessment of endothelial function during the loading phase of infliximab in psoriasis: a potential predictor of its drug survivalMomoko Nakao, Kouki Nakamura, Takemichi Fukasawa, et al.
The Journal of Dermatology|January 31, 2016
Decreased interleukin-21 expression in skin and blood in advanced mycosis fungoidesMiyoko Kabasawa, Makoto Sugaya, Tomonori Oka, et al.
Archives of Dermatological Research|December 3, 2013
Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Dermatology|October 19, 2017
Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosisMegumi Hirabayashi, Yoshihide Asano, Takashi Yamashita, et al.
Modern Rheumatology|March 6, 2014
Effect of ambrisentan on peripheral circulation in patients with systemic sclerosisHayakazu Sumida, Yoshihide Asano, Masaru Hatano, et al.
Plos One|March 3, 2012
A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosisShinji Noda, Yoshihide Asano, Kaname Akamata, et al.
The Journal of Dermatology|May 8, 2014
Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosusHayakazu Sumida, Yoshihide Asano, Zenshiro Tamaki, et al.
Journal of Dermatological Science|October 2, 2018
Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosisTakashi Yamashita, Yoshihide Asano, Ryosuke Saigusa, et al.
Journal of Dermatological Science|October 1, 2018
Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized sclerodermaTakuya Miyagawa, Yohei Ichimura, Kouki Nakamura, et al.
Modern Rheumatology|September 14, 2012
Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosisTakehiro Takahashi, Yoshihide Asano, Kaname Akamata, et al.
International Journal of Dermatology|September 1, 2018
Assessment of endothelial function during the loading phase of infliximab in psoriasis: a potential predictor of its drug survivalMomoko Nakao, Kouki Nakamura, Takemichi Fukasawa, et al.
The Journal of Dermatology|January 31, 2016
Decreased interleukin-21 expression in skin and blood in advanced mycosis fungoidesMiyoko Kabasawa, Makoto Sugaya, Tomonori Oka, et al.
Archives of Dermatological Research|December 3, 2013
Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Pageof 14